BackBasma Adeem Medical Overview

Basma Adeem Medical Current Assets

Track Basma Adeem Medical's current assets ($44M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$44.12M
↑ 16.02% YoYΔ $6.09M vs prior year quarter

Peer trimmed avg / median

Loading

Basma Adeem Medical Current Assets History

Loading

Basma Adeem Medical vs. peers: Current Assets Comparison

Loading

Basma Adeem Medical Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Basma Adeem Medical (9626.SR) FAQ

Basma Adeem Medical (9626.SR) currently reports a current assets of $44M as of June 2026. That compares with $38M in the prior-year period — up 16.0% year over year. Use the charts on this page to explore Basma Adeem Medical's current assets history and peer comparisons.

Basma Adeem Medical's current assets increased from $38M to $44M — a 16.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Basma Adeem Medical reported $44M in current assets as of June 2026. That compares with $38M in the prior-year period — up 16.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $44M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Basma Adeem Medical, and consider following 9626.SR for alerts when major investors trade the stock.